Common Contracts
7 similar Sales Agreement contracts by Sunesis Pharmaceuticals Inc, Compugen LTD, Introgen Therapeutics Inc, Sangamo Biosciences Inc
CONTROLLED EQUITY OFFERINGSM SALES AGREEMENTSales Agreement • September 1st, 2011 • Compugen LTD • Biological products, (no disgnostic substances) • New York
Sales AgreementSales Agreement • August 11th, 2011 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • New York
SUNESIS PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (“CF&Co”), as follows:
Sales AgreementSales Agreement • April 29th, 2010 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • New York
SUNESIS PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (“CF&Co”), as follows:
Sales AgreementSales Agreement • January 21st, 2010 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • New York
SUNESIS PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (“CF&Co”), as follows:
COMPUGEN LTD. $20,000,000 OF ORDINARY SHARES CONTROLLED EQUITY OFFERINGSM SALES AGREEMENTSales Agreement • October 30th, 2009 • Compugen LTD • Biological products, (no disgnostic substances) • New York
COMPUGEN LTD., a corporation formed under the laws of the State of Israel (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (“CF&Co”), as follows:
INTROGEN THERAPEUTICS, INC 6,000,000 SHARES CONTROLLED EQUITY OFFERINGSM SALES AGREEMENTSales Agreement • August 8th, 2008 • Introgen Therapeutics Inc • Pharmaceutical preparations • New York
INTROGEN THERAPEUTICS, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (“CF&Co”), as follows:
SANGAMO BIOSCIENCES, INC. 3,000,000 SHARES CONTROLLED EQUITY OFFERINGSM SALES AGREEMENTSales Agreement • May 18th, 2007 • Sangamo Biosciences Inc • Biological products, (no disgnostic substances) • New York
SANGAMO BIOSCIENCES, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (“CF&Co”), as follows:
